LabCorp

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes. Clinical teams can rely on PreciseDx for unmatched insights and actionable intelligence in determining the best treatment for each patient. Combining the power of artificial intelligence with its proprietary Morphology Feature Array™, PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making.

NOWDiagnostics, Inc. is a company based in Springdale, Arkansas, that specializes in the development and manufacturing of blood-based rapid diagnostic tests. Founded in 2013, the company offers innovative testing solutions that require only a single drop of blood, providing results within minutes. This approach empowers both patients and caregivers by enabling timely decision-making regarding healthcare. NOWDiagnostics' product line, ADEXUSDx, includes tests for various conditions such as pregnancy, cardiac events, and toxicology, all designed to be conducted in-home or in-clinic without the need for off-site laboratory processing. The company aims to reduce the waiting time for test results, enhancing the overall efficiency of medical diagnostics. NOWDiagnostics collaborates with strategic partners, including Zalgen Labs LLC, to expand its offerings in the diagnostic market.

Evvy is a company focused on improving female health by offering at-home vaginal microbiome tests. These tests utilize metagenomic sequencing to analyze symptoms and identify risks associated with important health issues. By providing personalized reports, Evvy aims to empower women with insights about their bodies, thereby addressing the gender health gap and enhancing overall health outcomes for women.

Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that connect diagnosis and treatment through a comprehensive ecosystem of devices, software, and services. By empowering patients to monitor their health and manage diseases, Vital Bio aims to enhance the overall healthcare experience. Their approach seeks to reduce disparities in healthcare outcomes and redistribute control to patients while equipping healthcare providers with the tools necessary to achieve better results.

Ovia Health offers a comprehensive maternity and family benefits solution that transforms the way women and families are supported throughout the parenthood journey. The company is formerly known as Ovuline is making healthcare a lifestyle. Its mobile apps, Ovia Fertility and Ovia Pregnancy, have helped millions of women start their families and live healthier lives.

Weavr Health is transforming blood collection by enabling patients to collect clinical-grade blood samples in their own homes without the need for a phlebotomist. The company has developed a self-collection device that allows average users to perform complex sample processing steps without requiring trained professionals or specialized laboratory equipment. This innovation simplifies the diagnostic testing process, making it more efficient and accessible at the point of care. By focusing on user-friendly solutions, Weavr Health aims to enhance the healthcare experience and streamline blood collection procedures.

Vivify Health Inc. operates a cloud-based, device-agnostic software platform that facilitates home-based remote monitoring, connecting healthcare providers with patients through consumer electronics. This platform aims to reduce hospital readmissions and associated healthcare costs by enabling virtual interactions between patients and doctors. Vivify Health offers various personal health devices, including tablets, weight scales, and pulse oximeters, to support its remote care management solutions. Founded in 2009 and based in Plano, Texas, the company was formerly known as Intuitive Health, Inc. and rebranded in May 2013. Vivify Health operates as a subsidiary of Optum, Inc., following a transaction announced in December 2019. Through its technology, the company seeks to enhance population health, optimize patient engagement, and improve overall patient satisfaction while facilitating the expansion of physician practice services.

LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.

DCL Medical Laboratories, Inc. provides a range of laboratory testing solutions, specializing in anatomic and molecular pathology services. The company offers diagnostic cytopathology and histopathology, as well as immunohistochemistry services that include a variety of antibodies for biomarker analysis and customized methodologies for processing biopsy specimens. DCL Medical Laboratories also supports clinical trials and delivers reference testing focused on women's health, including ThinPrep Pap test processing, HPV molecular testing, and screening for chlamydia, gonorrhea, and cystic fibrosis carriers. Serving the medical industry across the United States, DCL Medical Laboratories aims to enhance diagnostic accuracy and patient care through its comprehensive testing services.

Outcomes4Me Inc. is an AI-driven healthcare platform based in Cambridge, Massachusetts, founded in 2017. It focuses on empowering cancer patients by providing access to personalized, evidence-based treatment options and clinical information. The platform enables patients to navigate their care proactively, facilitating informed decision-making and improving health outcomes. By democratizing healthcare, Outcomes4Me promotes health equity and supports deeper insights into patient care, while also accelerating research and access to innovative treatments. The company is led by a team of experienced professionals from various sectors, including healthcare, oncology, and technology, dedicated to enhancing the patient experience in cancer treatment.